標題
返回
確定
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
Harbour BioMed
#
Harbour BioMed
About 7 search results
Sort by Date
Business
PR Newswire
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI
PR Newswire
2026-06-29 09:27
Harbour BioMed
Lloyd Klickstein
Immunology
Business
PR Newswire
Harbour BioMed and BioMap Jointly Initiate MegaStream TechBio: A Leading Global Drug Development Platform Joins Forces with Premier Life Science Foundation Models to Set New Benchmarks for AI-Driven Complex Biologics R&D
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI
PR Newswire
2026-06-15 20:10
Harbour BioMed
BioMap
MegaStream TechBio
Business
PR Newswire
Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI
PR Newswire
2026-06-15 08:01
Harbour BioMed
Amgen
patent infringement
Business
PR Newswire
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI
PR Newswire
2026-06-12 09:19
Harbour BioMed
Dhavalkumar Patel
Scientific Advisor
Business
PR Newswire
Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI
PR Newswire
2026-06-11 09:52
Harbour BioMed
Luisa Salter-Cid
Scientific Advisor
Business
PR Newswire
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI
PR Newswire
2026-06-10 12:06
Harbour BioMed
HBM7004
NMPA
Business
PR Newswire
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI
PR Newswire
2026-06-09 20:23
HBM9378/WIN378
COPD
Anti-TSLP Antibody